These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32953524)

  • 1. Rates of positive lung cancer screening examinations in academic versus community practice.
    Henderson LM; Bacchus L; Benefield T; Huamani Velasquez R; Rivera MP
    Transl Lung Cancer Res; 2020 Aug; 9(4):1528-1532. PubMed ID: 32953524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
    Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
    JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening in Appalachian Kentucky: The impact of Lung-RADS on subsequent testing and cancer identification.
    Cardarelli R; Madabhushi V; Bledsoe K; Weaver A
    J Clin Transl Sci; 2019 Sep; 4(5):468-471. PubMed ID: 33244438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: The PROSPR Consortium.
    Burnett-Hartman AN; Carroll NM; Honda SA; Joyce C; Mitra N; Neslund-Dudas C; Olaiya O; Rendle KA; Schnall MD; Vachani A; Ritzwoller DP
    Ann Am Thorac Soc; 2022 Mar; 19(3):433-441. PubMed ID: 34543590
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance of community-based lung cancer screening program in a Histoplasma endemic region.
    Bhandari S; Tripathi P; Pham D; Pinkston C; Kloecker G
    Lung Cancer; 2019 Oct; 136():102-104. PubMed ID: 31479878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Lung-RADS in Reducing False-Positive Results in a Diverse, Underserved, Urban Lung Cancer Screening Cohort.
    Kaminetzky M; Milch HS; Shmukler A; Kessler A; Peng R; Mardakhaev E; Bellin EY; Levsky JM; Haramati LB
    J Am Coll Radiol; 2019 Apr; 16(4 Pt A):419-426. PubMed ID: 30146484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
    Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
    JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
    Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
    Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment in relation to the detection of small pulmonary nodules.
    Field JK; Marcus MW; Oudkerk M
    Transl Lung Cancer Res; 2017 Feb; 6(1):35-41. PubMed ID: 28331822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
    Kim EY; Shim YS; Kim YS; Lee SP; Ko KD; Choi WJ
    PLoS One; 2019; 14(10):e0224224. PubMed ID: 31639166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community low-dose CT lung cancer screening: a prospective cohort study.
    Lam VK; Miller M; Dowling L; Singhal S; Young RP; Cabebe EC
    Lung; 2015 Feb; 193(1):135-9. PubMed ID: 25503535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial.
    Iaccarino JM; Silvestri GA; Wiener RS
    Chest; 2019 Nov; 156(5):965-971. PubMed ID: 31283920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography.
    Hoffman RM; Sussman AL; Getrich CM; Rhyne RL; Crowell RE; Taylor KL; Reifler EJ; Wescott PH; Murrietta AM; Saeed AI; Mishra SI
    Prev Chronic Dis; 2015 Jul; 12():E108. PubMed ID: 26160294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROC curves for low-dose CT in the National Lung Screening Trial.
    Pinsky PF; Gierada DS; Nath H; Kazerooni EA; Amorosa J
    J Med Screen; 2013; 20(3):165-8. PubMed ID: 24009092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
    Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
    JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the cancer risk management model lung cancer screening module.
    Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
    Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.